Michael Cotugno
Overview
Explore the profile of Michael Cotugno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hantel A, McManus M, Wadleigh M, Cotugno M, Abel G
J Natl Compr Canc Netw
. 2022 Apr;
20(4):335-341.e17.
PMID: 35390765
Background: Intermittent shortages of chemotherapeutics used to treat curable malignancies are a worldwide problem that increases patient mortality. Although multiple strategies have been proposed for managing these shortages (eg, prioritizing...
2.
Belisle C, Anger K, Kanaan D, Rocchio M, Triggs A, Chacon P, et al.
J Pharm Pract
. 2021 Jun;
36(1):46-52.
PMID: 34098782
The drug supply chain has suffered many interruptions over the past decade. The COVID-19 pandemic exacerbated an already fragile infrastructure for supplying critical medications to hospitals and health-systems. The purpose...
3.
Long J, Calabrese S, Al-Jedai A, Boyd A, Cotugno M, Dorn M, et al.
Am J Health Syst Pharm
. 2021 Feb;
78(9):800-805.
PMID: 33599751
Purpose: The proceedings of an international summit on the current and desired future state of use of robotic systems to compound intravenous (IV) solutions are summarized. Summary: The International IV...
4.
Vo P, Sylvia D, Milibari L, Stackhouse J, Szumita P, Rocchio M, et al.
Am J Health Syst Pharm
. 2021 Jan;
78(5):426-435.
PMID: 33471055
Purpose: Management of an acute shortage of parenteral opioid products at a large hospital through prescribing interventions and other guideline-recommended actions is described. Summary: In early 2018, many hospitals were...
5.
Milibari L, Cotugno M, Belisle C, Rocchio M, Patterson R, Chacon P, et al.
Int J Pharm Compd
. 2020 Jul;
24(4):346-351.
PMID: 32649308
The compounding of sterile medication admixtures is a labor-intensive process and subject to potential human error. The addition of robotic devices and workflow technology may mitigate some of the challenges...
6.
Pimentel M, Billings F, Sivashanker K, Sarin P, Fields K, Cotugno M, et al.
A A Pract
. 2020 Jun;
14(7):e01223.
PMID: 32539276
The relatively high cost of sugammadex compared to neostigmine limits its widespread use to reverse neuromuscular blockade, despite its faster onset and more complete clinical effect. While ensuring timely access...
7.
Stone A, Fields K, Rathmell J, Weiner S, Cotugno M, Pimentel M
Br J Anaesth
. 2020 May;
124(6):e219-e221.
PMID: 32359691
No abstract available.
8.
Dietzek A, Connelly K, Cotugno M, Bartel S, McDonnell A
J Oncol Pharm Pract
. 2014 Jan;
21(2):143-7.
PMID: 24415364
Background: Denosumab is a nuclear factor-kappa ligand monoclonal antibody whose FDA-approved indications include treatment of osteoporosis, bone loss with certain anticancer hormonal agents, and prevention of skeletal-related events in patients...
9.
Rough S, Shane R, Phelps P, Klauck J, Donnelly A, Besier J, et al.
Am J Health Syst Pharm
. 2012 Sep;
69(19):1687-93.
PMID: 22997123
No abstract available.